A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
Clinical trial NCT00516945 · COMPLETED
Trial details
- NCT number
- NCT00516945
- Sponsor
- Hospital Authority, Hong Kong
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.